Polysaccharides

prion protein ; Homo sapiens







37 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35095219 Short-time acoustic and hydrodynamic cavitation improves dispersibility and functionality of pectin-rich biopolymers from citrus waste. 2022 Jan 1 1
2 32321762 α2,3 linkage of sialic acid to a GPI anchor and an unpredicted GPI attachment site in human prion protein. 2020 May 29 4
3 22665612 Naturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in Mali. 2012 Jun 1
4 19395868 Safety and immunogenicity of an indigenously developed Haemophilus influenzae type b conjugate vaccine through various phases of clinical trials. 2009 Jul 1
5 18939501 [Hib vaccine]. 2008 Oct 1
6 17996996 A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants. 2007 Dec 12 1
7 16414019 Prion protein-related proteins from zebrafish are complex glycosylated and contain a glycosylphosphatidylinositol anchor. 2006 Mar 3 1
8 16424597 Surveillance of natural acquired antibodies to Haemophilus influenzae type b among children in Cairo-Egyptian. 2005 1
9 11500820 Carrier-mediated enhancement of cognate T cell help: the basis for enhanced immunogenicity of meningococcal outer membrane protein polysaccharide conjugate vaccine. 2001 Aug 1
10 10775792 Differing serologic responses to an haemophilus influenzae type b polysaccharide-neisseria meningitidis outer membrane protein conjugate (PRP-OMPC) vaccine in australian aboriginal and caucasian infants - implications for disease epidemiology. 2000 May 22 1
11 10959738 Absence of a significant interaction between a Haemophilus influenzae conjugate vaccine combined with a diphtheria toxoid, tetanus toxoid and acellular pertussis vaccine in the same syringe and inactivated polio vaccine. 2000 Aug 1
12 11030742 Molecular dynamics simulation of human prion protein including both N-linked oligosaccharides and the GPI anchor. 2000 Oct 1
13 9473220 Prion protein expression in human leukocyte differentiation. 1998 Mar 1 1
14 9761736 Sulphated glycosaminoglycans prevent the neurotoxicity of a human prion protein fragment. 1998 Oct 15 1
15 10934551 Safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine (PedvaxHIB) in Papua New Guinean children. 1998 Sep-Dec 1
16 9007484 Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine. 1997 Jan 2
17 9066028 Phase I study of the immunogenicity and safety of conjugated Hemophilus influenzae type b vaccines in the elderly. 1997 Feb 1
18 9427456 Haemophilus influenzae type b-specific antibody in infants after maternal immunization. 1997 Dec 2
19 8961512 Priming with diphtheria-tetanus-pertussis vaccine enhances the response to the Haemophilus influenzae type b tetanus conjugate vaccine in infancy. 1996 Sep 2
20 7700752 Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period. 1995 Apr 2
21 7798688 Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines. 1995 Jan 2
22 7812655 Prion protein and the scrapie agent: in vitro studies in infected neuroblastoma cells. 1994 Apr-Jun 1
23 8030949 Scrapie-associated PrP accumulation and its inhibition: revisiting the amyloid-glycosaminoglycan connection. 1994 Jun 6 2
24 7678300 Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. 1993 Feb 1
25 8137133 Scrapie associated PrP accumulation and its prevention: insights from cell culture. 1993 Oct 1
26 8337029 Effectiveness and safety of an Haemophilus influenzae type b conjugate vaccine (PRP-T) in young infants. Kaiser-UCLA Vaccine Study Group. 1993 Aug 1
27 1552207 Correlation between antibody affinity and serum bactericidal activity in infants. 1992 Apr 1
28 1588147 Maternal immunization with the capsular polysaccharide vaccine for Haemophilus influenzae type b. 1992 Jun 1
29 1640282 Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. 1992 Aug 2
30 1667038 [Evaluation of the vaccination of 3-month-old infants with Haemophilus influenzae type B (Hi b) capsular polysaccharide conjugated to tetanus protein (PRT-T) Pediatric Group of the Lyon Region]. 1991 2
31 1891953 Biological activity of Hib conjugates. 1991 Jun 1
32 2058604 Dose-related immunogenicity of Haemophilus influenzae type b capsular polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine. 1991 Jul 1
33 2235187 Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease. 1990 Sep 1
34 3491858 Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid. 1987 Jan 1
35 3497990 Safety and immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine (PRP-D) in infants. 1987 Oct 1
36 3874882 Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197. 1985 Jul 1
37 3875705 Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b. 1985 Sep 1